PT Millennium Pharmacon International Tbk reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was IDR 813,456.27 million compared to IDR 683,789.03 million a year ago. Net income was IDR 11,103.56 million compared to IDR 890.76 million a year ago. Basic earnings per share from continuing operations was IDR 8.72 compared to IDR 0.7 a year ago.